UK Markets close in 5 hrs 23 mins

Novartis AG (NVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
86.89+0.55 (+0.64%)
At close: 04:00PM EST
88.07 +1.18 (+1.36%)
Pre-market: 05:32AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 394.26
52-week low 374.09
50-day moving average 390.36
200-day moving average 385.15

Share statistics

Avg vol (3-month) 32.07M
Avg vol (10-day) 32.64M
Shares outstanding 52.12B
Implied shares outstanding 6N/A
Float 82.08B
% held by insiders 10.01%
% held by institutions 19.20%
Shares short (13 Oct 2022) 46.08M
Short ratio (13 Oct 2022) 42.3
Short % of float (13 Oct 2022) 4N/A
Short % of shares outstanding (13 Oct 2022) 40.28%
Shares short (prior month 14 Sept 2022) 45.59M

Dividends & splits

Forward annual dividend rate 43.33
Forward annual dividend yield 44.24%
Trailing annual dividend rate 33.40
Trailing annual dividend yield 33.94%
5-year average dividend yield 43.52
Payout ratio 432.60%
Dividend date 319 Mar 2023
Ex-dividend date 407 Mar 2022
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 41.71%
Operating margin (ttm)20.94%

Management effectiveness

Return on assets (ttm)5.71%
Return on equity (ttm)36.99%

Income statement

Revenue (ttm)52.26B
Revenue per share (ttm)23.68
Quarterly revenue growth (yoy)-3.90%
Gross profit (ttm)37.44B
Net income avi to common (ttm)21.8B
Diluted EPS (ttm)3.48
Quarterly earnings growth (yoy)-43.00%

Balance sheet

Total cash (mrq)19.1B
Total cash per share (mrq)8.81
Total debt (mrq)28.54B
Total debt/equity (mrq)46.86
Current ratio (mrq)1.31
Book value per share (mrq)22.50

Cash flow statement

Operating cash flow (ttm)14.01B
Levered free cash flow (ttm)10.9B